X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
antimitotic agents (2) 2
antineoplastic agents (2) 2
breast cancer (2) 2
chemotherapy (2) 2
follow-up (2) 2
product development (2) 2
trastuzumab (2) 2
adenocarcinoma (1) 1
adult (1) 1
aged (1) 1
aged, 80 and over (1) 1
analysis (1) 1
angina pectoris (1) 1
antibodies, monoclonal, humanized - administration & dosage (1) 1
antibodies, monoclonal, humanized - adverse effects (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
breast (1) 1
breast neoplasms - chemistry (1) 1
breast neoplasms - drug therapy (1) 1
breast neoplasms - genetics (1) 1
breast neoplasms - mortality (1) 1
breast neoplasms - secondary (1) 1
breast neoplasms - surgery (1) 1
cancer (1) 1
cancer therapies (1) 1
care and treatment (1) 1
chemotherapy, adjuvant (1) 1
clinical trials (1) 1
consent (1) 1
data dictionaries (1) 1
disease-free survival (1) 1
drug administration schedule (1) 1
early detection of cancer (1) 1
ejection (1) 1
erbb-2 protein (1) 1
ethics (1) 1
etymology (1) 1
female (1) 1
france (1) 1
french (1) 1
french language (1) 1
heart (1) 1
heart diseases - chemically induced (1) 1
hematology, oncology and palliative medicine (1) 1
hera (1) 1
humans (1) 1
index medicus (1) 1
infusions, intravenous (1) 1
joint analysis (1) 1
kaplan-meier estimate (1) 1
mastectomy (1) 1
mean survival-time (1) 1
medicine, general & internal (1) 1
metastases (1) 1
middle aged (1) 1
motivation (1) 1
names (1) 1
names, personal (1) 1
neoplasm recurrence, local (1) 1
neoplasms, second primary (1) 1
nodes (1) 1
oncology (1) 1
patients (1) 1
predictive value of tests (1) 1
proportional hazards models (1) 1
protein kinase inhibitors - administration & dosage (1) 1
protein kinase inhibitors - adverse effects (1) 1
radiotherapy, adjuvant (1) 1
randomization (1) 1
receptor, erbb-2 - analysis (1) 1
receptor, erbb-2 - genetics (1) 1
safety (1) 1
statistical analysis (1) 1
studies (1) 1
subgroups (1) 1
survival (1) 1
time factors (1) 1
treatment outcome (1) 1
tumors (1) 1
ventricle (1) 1
young adult (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 8, pp. 741 - 748
Summary Background Since 2005, 12 months of adjuvant trastuzumab has been the standard treatment for patients with HER2-positive early-stage breast cancer.... 
Hematology, Oncology and Palliative Medicine | ONCOLOGY | FOLLOW-UP | CHEMOTHERAPY | Breast Neoplasms - surgery | Predictive Value of Tests | Breast Neoplasms - secondary | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Young Adult | Breast Neoplasms - chemistry | Antibodies, Monoclonal, Humanized - administration & dosage | Neoplasms, Second Primary | Time Factors | Antineoplastic Agents - adverse effects | Aged, 80 and over | Mastectomy | Adult | Female | Chemotherapy, Adjuvant | France | Heart Diseases - chemically induced | Radiotherapy, Adjuvant | Antibodies, Monoclonal, Humanized - adverse effects | Drug Administration Schedule | Early Detection of Cancer | Kaplan-Meier Estimate | Neoplasm Recurrence, Local | Proportional Hazards Models | Treatment Outcome | Breast Neoplasms - drug therapy | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Breast Neoplasms - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - mortality | Aged | Infusions, Intravenous | Receptor, ErbB-2 - analysis | Trastuzumab | Antimitotic agents | Care and treatment | Clinical trials | Breast cancer | Product development | Antineoplastic agents | Cancer | Index Medicus
Journal Article
by Pivot, Xavier and Romieu, Gilles and Debled, Marc and Pierga, Jean-Yves and Kerbrat, Pierre and Bachelot, Thomas and Lortholary, Alain and Espié, Marc and Fumoleau, Pierre and Serin, Daniel and Jacquin, Jean-Philippe and Jouannaud, Christelle and Rios, Maria and Abadie-Lacourtoisie, Sophie and Venat-Bouvet, Laurence and Cany, Laurent and Catala, Stéphanie and Khayat, David and Gambotti, Laetitia and Pauporté, Iris and Faure-Mercier, Celine and Paget-Bailly, Sophie and Henriques, Julie and Grouin, Jean Marie and Piprot, C and Cals, L and Chaigneau, L and Demarchi, F and N'Guyen, T and Stein, U and Villanueva, C and Bréau, JL and Chouahnia, AK and Saintigny, P and Boué, F and deSaint-Hilaire, P and Guimont, I and Grossat, N and Valenza, B and Lévy, E and Médioni, J and Delbaldo, C and Grenier, J and Pouessel, D and Lavau-Denès, S and Falandry, C and Fournel-Fédérico, C and Freyer, G and Tartas, S and Trillet-Lenoir, V and Bons, F and Auclerc, G and Chièze, S and Raban, N and Tournigand, C and Trager-Maury, S and Bousquet, G and Cuvier, C and Giacchetti, S and Hocini, A and LeMaignan, C and Misset, JL and Avenin, D and Beerblock, C and Gligorov, J and Rivera, P and Roché, H and Bougnoux, P and Hajjaji, N and Capitain, O and Delva, R and Maillart, P and Soulié, P and Bonnefoi, H and Durand, M and Madranges, N and Mauriac, L and Chollet, P and Dillies, AF and Durando, X and Ferrière, JP and Mouret-Reynier, C and Nabholtz, JM and Van Praagh, I and Cottu, P and Diéras, V and Durieux, A and Galotte, M and Girre, V and Henry, S and Iurisci, I and Jouve, M and Laurence, V and Mignot, L and Piperno-Neumann, S and Tresca, P and Coudert, B and Ferrant, E and Mayer, F and Vanneuville, AC and ... and PHARE Trial Investigators and PHARE trial investigators
The Lancet, ISSN 0140-6736, 06/2019, Volume 393, Issue 10191, pp. 2591 - 2598
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.